IntraCellular Therapies (ITCI)
(Delayed Data from NSDQ)
$73.12 USD
-0.89 (-1.20%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $73.47 +0.35 (0.48%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.32 | -14.14% |
Earnings Summary
For their last quarter, IntraCellular Therapies (ITCI) reported earnings of -$0.30 per share, beating the Zacks Consensus Estimate of $-0.44 per share. This reflects a positive earnings surprise of 31.82%. Look out for ITCI's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.32 per share, reflecting a year-over-year increase of 30.43%.
Earnings History
Price & Consensus
Zacks News for ITCI
Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals
ITCI: What are Zacks experts saying now?
Zacks Private Portfolio Services